HBI speaks exclusively to George Spanos, chairman and CEO of Greece's largest primary care and diagnostic chain, about the company's plans for the future and whether rumours the company might be for sale are true.
Grupo 5 has carved out an unusual but successful niche for itself in Spain, balancing a mix of healthcare services (predominantly mental health and treatment for patients with brain injuries) with social emergency care for the homeless, children, and people with disability. CEO Guillermo Bell tells HBI it has proved to be a robust combination during the COVID crisis.
What is the outlook for the UK teleradiology sector, with the largest player Medica's elective volumes still less than half of pre-COVID levels? We talk to CEO Stuart Quin about the group's recent H1 results and its strategy around specialist reporting, AI solutions, diversification and internationalisation, the latter of which has shifted since we last spoke.
Fresenius Helios has a new incoming digital health executive, who after heading up the Fresenius Group's German rehab business for the past four years wants to disrupt the way it manages chronic disease by transforming it from a pure hospital operator into a digi-physical healthcare group. Leister tells HBI that he wants to sell its digital therapeutics solution Curalie right into emerging markets.
Switzerland's second-largest for-profit hospital group Swiss Medical Network (SMN) has acquired a primary and outpatient care centre in Bern, but the deal was "not done to steer more patients to the group’s hospitals," a spokesperson tells us. We look at the primary care market in Switzerland and how SMN's approach to it differs from competitors.
Max India, the conglomerate that recently sold a large stake in hospital chain Max Healthcare, has announced it will expand its elderly care business in India by moving into mid-market independent living, medicalised nursing homes and homecare.
The CEO of City & County Healthcare, the second-largest domiciliary care provider in the UK with 2019 revenue of £ 236m, tells HBI how the company is navigating the COVID-19 crisis and what prospects are now like for a sale.
Pan-European dental group Curaeos has reportedly struck a deal with some of its creditors in a move that will lighten the company's debt while transferring a minority stake.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
